Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Rainforest Pharmacal

Rainforest Pharmacal
Out of Business LATEST DEAL TYPE

Developer of bio-pharmaceuticals designed to offer anticancer therapies. The company's bio-pharmaceuticals include novel anticancer drugs developed from anticancer botanical extracts, that target the cancer cells. minimizing damage to the rest of the body, enabling cancer patients to be treated in a better way so that they lead a healthy life.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 19141 Stone Oak Parkway
  • Suite 104
  • San Antonio, TX 78258
  • United States

+1 (210) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Rainforest Pharmacal’s full profile, request a free trial.

Rainforest Pharmacal Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-May-2018 Completed Out of Business
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Rainforest Pharmacal Executive Team (4)

Name Title Board
Charles Mazinter Founder, Chief Executive Officer & Chairman of the Board
David Browning President
Mark Staples Ph.D Chief Scientific Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Rainforest Pharmacal Board Members (1)

Name Representing Role Since Contact
Charles Mazinter Rainforest Pharmacal Founder, Chief Executive Officer & Chairman of the Board 000 0000